English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Neutrophil Elastase Enhances Sputum Solubilization in Cystic Fibrosis Patients Receiving DNase Therapy

MPS-Authors
/persons/resource/persons82088

Papayannopoulos,  Venizelos
Department of Cellular Microbiology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82241

Zychlinsky,  Arturo
Department of Cellular Microbiology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

PLOS_One_2011_6_e28526.pdf
(Publisher version), 1004KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Papayannopoulos, V., Staab, D., & Zychlinsky, A. (2011). Neutrophil Elastase Enhances Sputum Solubilization in Cystic Fibrosis Patients Receiving DNase Therapy. PLoS ONE, 6(12): e28526. doi:10.1371/journal.pone.0028526.


Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-BE7A-7
Abstract
Cystic fibrosis patients suffer from chronic lung infection and inflammation due to the secretion of viscous sputum. Sputum viscosity is caused by extracellular DNA, some of which originates from the release of neutrophil extracellular traps (NETs). During NET formation neutrophil elastase (NE) partially processes histones to decondense chromatin. NE is abundant in CF sputum and is thought to contribute to tissue damage. Exogenous nucleases are a palliative treatment in CF as they promote sputum solubilization. We show that in a process reminiscent of NET formation, NE enhances sputum solubilization by cleaving histones to enhance the access of exogenous nucleases to DNA. In addition, we find that in Cf sputum NE is predominantly bound to DNA, which is known to downregulate its proteolytic activity and may restrict host tissue damage. The beneficial role of NE in CF sputum solubilization may have important implications for the development of CF therapies targeting NE.